Investing.com - Smith & Wesson (NASDAQ: SWBI) reported fourth quarter EPS of $0.45, $0.09 better than the analyst estimate of $0.36. Revenue for the quarter came in at $159.1M versus the consensus estimate of $156.8M.
Smith & Wesson's stock price closed at $16.40. It is down -7.24% in the last 3 months and up 40.17% in the last 12 months.
Smith & Wesson saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Smith & Wesson's stock price’s past reactions to earnings here.
According to InvestingPro, Smith & Wesson's Financial Health score is "fair performance".
Check out Smith & Wesson's recent earnings performance, and Smith & Wesson's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar